Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP2182933

NOVEL MEDICAMENT IN POWDER FORM COMPRISING TIOTROPIUM AND SALMETEROL, AND LACTOSE AS EXCIPIENT

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    18.7.2008
  • EP published:
    7.9.2016
  • EP application number:
    08786245.4
  • Max expiry date:
    17.7.2028
  • Title:
    NOVEL MEDICAMENT IN POWDER FORM COMPRISING TIOTROPIUM AND SALMETEROL, AND LACTOSE AS EXCIPIENT

Timeline

Today
18.7.2008EP application
7.9.2016EP Publication

Owner

  • Name:
    Boehringer Ingelheim International GmbH
  • Address:
    Binger Strasse 173, 55216, Ingelheim am Rhein, DE

Inventor

  • Name:
    WALZ, Michael
  • Address:
    Ingelheim am Rhein, DE
  • Name:
    OSSADNIK, Stephanie
  • Address:
    Ingelheim am Rhein, DE
  • Name:
    TRUNK, Michael
  • Address:
    Ingelheim am Rhein, DE
  • Name:
    KREHER, Christoph
  • Address:
    Ingelheim am Rhein, DE

Priority

  • Number:
    102007034157
  • Date:
    21.7.2007
  • Country:
    DE
  • Number:
    51933 P
  • Date:
    9.5.2008
  • Country:
    US

Classification

  • Categories:
    A61K 9/72, A61K 31/137, A61K 31/46

Upload documents